Tatva Chintan Pharma Chem
NSE: TATVA · ISIN INE0GK401011 · Basic Materials
₹1,648.30+23.90 (+1.47%)
Monday 9 November, 12:47 IST. Delayed. Source: Yahoo Finance.
Price chart
₹1,648.30 +23.90 (+1.47%) today
The day
- Previous close
- ₹1,624.40
- Open
- ₹1,630.00
- Day high
- ₹1,654.70
- Day low
- ₹1,602.10
Listed on NSE since 29 July 2021.
Key numbers
- Market value
- ₹3,799.81 Cr
- P/E (trailing)
- 60.39
- EPS (trailing)
- ₹26.90
- Price to book
- 4.66
- Dividend yield
- 0.12%
- Return on equity
- 8.0%
- Debt to equity
- 0.21
- Profit margin
- 9.7%
- Beta
- 0.32
- Volume today
- 23,433
- Average volume
- 92,425
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹420.89 Cr | ₹45.49 Cr |
| FY24 | ₹390.50 Cr | ₹30.35 Cr |
| FY25 | ₹379.90 Cr | ₹5.71 Cr |
| FY26 | ₹500.62 Cr | ₹42.05 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹217 Cr | ₹21 Cr | +116.3% |
| Q1 FY27Apr–Jun 2026 | ₹167 Cr | ₹16 Cr | +140.3% |
| Q4 FY26Jan–Mar 2026 | ₹134 Cr | ₹10 Cr | +902.0% |
| Q3 FY26Oct–Dec 2025 | ₹131 Cr | ₹15 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹124 Cr | ₹10 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹117 Cr | ₹7 Cr | – |
Source: Tatva Chintan Pharma Chem’s results filed with NSE, consolidated (the whole group). Net profit is the share of Tatva Chintan Pharma Chem’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹632 Cr | ₹627 Cr |
| Investments | ₹4 Cr | ₹4 Cr |
| Inventories | ₹249 Cr | ₹196 Cr |
| Owed by customers | ₹178 Cr | ₹119 Cr |
| Cash and equivalents | ₹11 Cr | ₹6 Cr |
| Total assets | ₹1,119 Cr | ₹1,004 Cr |
| Borrowings | ₹170 Cr | ₹120 Cr |
| Total liabilities | ₹304 Cr | ₹222 Cr |
| Shareholders’ equity | ₹815 Cr | ₹782 Cr |
Source: Tatva Chintan Pharma Chem’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
- Industry
- Specialty Chemicals
- Based in
- Vadodara
- Employees
- 793
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Tatva Chintan Pharma Chem in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 2 Per Share
Dividend · ex-date 11 September 2026
- Dividend - Re 1 Per Share
Dividend · ex-date 12 September 2025
- Annual General Meeting
Action · ex-date 6 September 2024
- Dividend - Rs 2 Per Share
Dividend · ex-date 6 September 2024
- Annual General Meeting
Action · ex-date 8 September 2023
- Dividend - Rs 2 Per Share
Dividend · ex-date 8 September 2023
- Annual General Meeting
Action · ex-date 8 September 2022
- Dividend - Rs 2 Per Share
Dividend · ex-date 8 September 2022 · record date 9 September 2022
Source: NSE. Latest first, 8 of 9.
Information only, not investment advice. Prices are delayed.